Multiparametric 3T MR approach to the assessment of cerebral gliomas: tumor extent and malignancy
- PMID: 16752135
- DOI: 10.1007/s00234-006-0102-3
Multiparametric 3T MR approach to the assessment of cerebral gliomas: tumor extent and malignancy
Abstract
Introduction: Contrast-enhanced MR imaging is the method of choice for routine assessment of brain tumors, but it has limited sensitivity and specificity. We verified if the addition of metabolic, diffusion and hemodynamic information improved the definition of glioma extent and grade.
Methods: Thirty-one patients with cerebral gliomas (21 high- and 10 low-grade) underwent conventional MR imaging, proton MR spectroscopic imaging ((1)H-MRSI), diffusion weighted imaging (DWI) and perfusion weighted imaging (PWI) at 3 Tesla, before undergoing surgery and histological confirmation. Normalized metabolite signals, including choline (Cho), N-acetylaspartate (NAA), creatine and lactate/lipids, were obtained by (1)H-MRSI; apparent diffusion coefficient (ADC) by DWI; and relative cerebral blood volume (rCBV) by PWI.
Results: Perienhancing areas with abnormal MR signal showed 3 multiparametric patterns: "tumor", with abnormal Cho/NAA ratio, lower ADC and higher rCBV; "edema", with normal Cho/NAA ratio, higher ADC and lower rCBV; and "tumor/edema", with abnormal Cho/NAA ratio and intermediate ADC and rCBV. Perienhancing areas with normal MR signal showed 2 multiparametric patterns: "infiltrated", with high Cho and/or abnormal Cho/NAA ratio; and "normal", with normal spectra. Stepwise discriminant analysis showed that the better classification accuracy of perienhancing areas was achieved when regarding all MR variables, while (1)H-MRSI variables and rCBV better differentiated high- from low-grade gliomas.
Conclusion: Multiparametric MR assessment of gliomas, based on (1)H-MRSI, PWI and DWI, discriminates infiltrating tumor from surrounding vasogenic edema or normal tissues, and high- from low-grade gliomas. This approach may provide useful information for guiding stereotactic biopsies, surgical resection and radiation treatment.
Similar articles
-
Measurements of diagnostic examination performance using quantitative apparent diffusion coefficient and proton MR spectroscopic imaging in the preoperative evaluation of tumor grade in cerebral gliomas.Eur J Radiol. 2011 Nov;80(2):462-70. doi: 10.1016/j.ejrad.2010.07.017. Epub 2010 Aug 13. Eur J Radiol. 2011. PMID: 20708868
-
Spectroscopic, diffusion and perfusion magnetic resonance imaging at 3.0 Tesla in the delineation of glioblastomas: preliminary results.J Exp Clin Cancer Res. 2006 Sep;25(3):383-90. J Exp Clin Cancer Res. 2006. PMID: 17167979
-
Recurrent glioblastoma multiforme versus radiation injury: a multiparametric 3-T MR approach.Radiol Med. 2014 Aug;119(8):616-24. doi: 10.1007/s11547-013-0371-y. Epub 2014 Jan 10. Radiol Med. 2014. PMID: 24408041
-
Differentiating surgical from non-surgical lesions using perfusion MR imaging and proton MR spectroscopic imaging.Technol Cancer Res Treat. 2004 Dec;3(6):557-65. doi: 10.1177/153303460400300605. Technol Cancer Res Treat. 2004. PMID: 15560713 Review.
-
3 Tesla magnetic resonance spectroscopy: cerebral gliomas vs. metastatic brain tumors. Our experience and review of the literature.Int J Neurosci. 2013 Aug;123(8):537-43. doi: 10.3109/00207454.2013.774395. Epub 2013 Mar 11. Int J Neurosci. 2013. PMID: 23390934 Review.
Cited by
-
Institutional review of glial tumors treated with chemotherapy: the first description of PCV-related pseudoprogression.Neurooncol Pract. 2019 Jan;6(1):22-29. doi: 10.1093/nop/npy012. Epub 2018 May 21. Neurooncol Pract. 2019. PMID: 31385994 Free PMC article.
-
Updates in IDH-Wildtype Glioblastoma.Neurotherapeutics. 2022 Oct;19(6):1705-1723. doi: 10.1007/s13311-022-01251-6. Epub 2022 May 31. Neurotherapeutics. 2022. PMID: 35641844 Free PMC article. Review.
-
Differentiation of edema and glioma infiltration: proposal of a DTI-based probability map.J Neurooncol. 2014 Oct;120(1):187-98. doi: 10.1007/s11060-014-1544-9. Epub 2014 Jul 31. J Neurooncol. 2014. PMID: 25079117
-
A Phase 2 Study of Dose-intensified Chemoradiation Using Biologically Based Target Volume Definition in Patients With Newly Diagnosed Glioblastoma.Int J Radiat Oncol Biol Phys. 2021 Jul 1;110(3):792-803. doi: 10.1016/j.ijrobp.2021.01.033. Epub 2021 Jan 29. Int J Radiat Oncol Biol Phys. 2021. PMID: 33524546 Free PMC article. Clinical Trial.
-
Magnetic resonance biomarkers in radiation oncology: The report of AAPM Task Group 294.Med Phys. 2021 Jul;48(7):e697-e732. doi: 10.1002/mp.14884. Epub 2021 May 20. Med Phys. 2021. PMID: 33864283 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical